Effects of FATmax Exercise and HIIT on Fat Loss in Overweight Young Women

November 5, 2024 updated by: Beijing Sport University

Effects of Maximal Fat Oxidation Exercise and High-intensity Interval Training on Fat Loss in Overweight Young Women

This study investigated the effects of two exercise modalities: high-intensity interval training (HIIT) and maximal fat oxidation (FATmax) exercise on fat loss in overweight young women. Participants were randomly assigned to either the HIIT or FATmax group, underwent an 8-week supervised exercise intervention.

Study Overview

Detailed Description

This study aims to compare the effects of HIIT and FATmax exercise on fat loss in overweight young women. Participants were recruited and randomly assigned to either the HIIT group or the FATmax group. The intervention lasted for 8 weeks, during which participants maintained their usual diet. Both body morphology and body composition were assessed before and after the intervention. In order to recommend exercise strategy for overweight young women reduce fat and improve their health.

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Beijing, China
        • School of Sports Medicine and Rehabilitation, Beijing Sport University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Female, aged between 18 and 30 years.
  • Overweight, BMI greater than 24.0 kg·m-2.
  • Participants Lack of exercise habits.
  • Participants Without significant fluctuation in weight.

Exclusion Criteria:

  • Participants took drugs affecting metabolism and hormones during the experimental period.
  • Participants had a history of oral weight loss pills and contraceptive pills.
  • Participants had a history of smoking, alcohol consumption, or daily consumption of caffeine-containing beverages.
  • Participants had cardiovascular or basal metabolic disorders, such as hypertension, coronary heart disease, or diabetes mellitus.
  • Participants had other acute or chronic injuries related to exercise.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: HIIT group
High-intensity interval training
Experimental: FATmax group
Maximal fat oxidation exercise

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body weight
Time Frame: 8 weeks
The change of body weight before and after intervention.
8 weeks
Body mass index (BMI)
Time Frame: 8 weeks
The change of body mass index before and after intervention.
8 weeks
Waist circumference
Time Frame: 8 weeks
The change of waist circumference before and after intervention.
8 weeks
Hip circumference
Time Frame: 8 weeks
The change of hip circumference before and after intervention.
8 weeks
Body fat weight
Time Frame: 8 weeks
The change of body fat weight before and after intervention.
8 weeks
Body fat percentage
Time Frame: 8 weeks
The change of body fat percentage before and after intervention.
8 weeks
Visceral fat area
Time Frame: 8 weeks
The change of visceral fat area before and after intervention.
8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Height
Time Frame: 8 weeks
The change of height before and after intervention.
8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 15, 2021

Primary Completion (Actual)

September 30, 2021

Study Completion (Actual)

December 30, 2021

Study Registration Dates

First Submitted

November 5, 2024

First Submitted That Met QC Criteria

November 5, 2024

First Posted (Actual)

November 6, 2024

Study Record Updates

Last Update Posted (Actual)

November 6, 2024

Last Update Submitted That Met QC Criteria

November 5, 2024

Last Verified

November 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • EOMFOEAHITOFLIOYW

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Overweight

Clinical Trials on High-intensity interval training

Subscribe